Updated Jul 16, 2026
Durso Jerome Benedict is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $118K.
Jerome Benedict Durso is the CEO-elect and a director at Altimmune, Inc., a biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's strategic direction and clinical development efforts.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-01 | ALT | Altimmune, Inc. | P — Open-market purchase | 15.0K | $3.14 | $47K |
| 2026-03-09 | ALT | Altimmune, Inc. | P — Open-market purchase | 20.0K | $3.54 | $71K |
Jerome Benedict Durso is the CEO-elect and a director at Altimmune, Inc., a biopharmaceutical company focused on developing treatments for obesity and metabolic diseases. He has been involved in the company's strategic direction and clinical development efforts.…
Recorded transactions: 2 open-market purchases ($118K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Durso Jerome Benedict profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.